TABLE 3.
tPMP-1 (μg/ml) | Mean ± SD % survival ofa:
|
||||||||
---|---|---|---|---|---|---|---|---|---|
SK982 | SK2355(pSK1) | SK4787(pSK105) | SK2413(pSK107) | SK4027(pSK638) | SK5127(pSK30) | SK2269(pSK78) | NCTC8325 | SK2237(pSK1) | |
12 | 2 ± 1 | 7 ± 1 | 8 ± 3 | 6 ± 2 | 11 ± 2 | 2 ± 1 | 5 ± 2 | 2 ± 0.3 | 15 ± 2 |
6 | 10 ± 4 | 19 ± 4 | 14 ± 2 | 13 ± 2 | 15 ± 1 | 11 ± 5 | 14 ± 3 | 4 ± 1 | 36 ± 4 |
4 | 12 ± 3 | 37 ± 4 | 30 ± 4 | 28 ± 3 | 33 ± 2 | 15 ± 3 | 19 ± 2 | 17 ± 2 | 43 ± 5 |
3 | 15 ± 2 | 83 ± 5 | 61 ± 4 | 64 ± 3 | 62 ± 5 | 19 ± 4 | 28 ± 3 | 15 ± 4 | 69 ± 4 |
2 | 15 ± 2 | 91 ± 4 | 76 ± 5 | 85 ± 5 | 89 ± 6 | 21 ± 3 | 31 ± 4 | 20 ± 3 | 83 ± 4 |
After 2 h of in vitro exposure under the given conditions. Results represent the mean of three independent experiments.